Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 40

Results For "strategy"

790 News Found

Agilent showcases cancer portfolio Solutions at AACR 2023
Digitisation | April 18, 2023

Agilent showcases cancer portfolio Solutions at AACR 2023

From cancer research to diagnostic solutions


Chiesi Farmaceutici completes acquisition of Amryt Pharma
News | April 15, 2023

Chiesi Farmaceutici completes acquisition of Amryt Pharma

Acquisition positions Chiesi to expand patient access to approved treatments and advance efforts to develop new treatments for people living with rare diseases.


India’s Covid success story hailed the world over as a role model in Crisis Management, says Dr. Singh
Policy | April 13, 2023

India’s Covid success story hailed the world over as a role model in Crisis Management, says Dr. Singh

India's strategy against Covid was more effective than any other countries in the world


LifeSigns introduces ‘Continuum Care’ for Patients
Medical Device | April 13, 2023

LifeSigns introduces ‘Continuum Care’ for Patients

Enabling wireless monitoring In ambulances and homes


Apitoria Pharma  appoints Dr. Sanjay Chaturvedi as CEO
People | April 06, 2023

Apitoria Pharma appoints Dr. Sanjay Chaturvedi as CEO

Venkat Nageswar Chalasani has been appointed as an Independent Director of Apitoria Pharma with effect from April 4, 2023


Top management changes at IOL Chemicals and Pharmaceuticals
People | April 04, 2023

Top management changes at IOL Chemicals and Pharmaceuticals

Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company


CBC Group appoints Abbas Hussain as Operating Partner
People | April 03, 2023

CBC Group appoints Abbas Hussain as Operating Partner

Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions


EIP Pharma and Diffusion Pharmaceuticals inks agreement to create CNS-focused company
News | April 03, 2023

EIP Pharma and Diffusion Pharmaceuticals inks agreement to create CNS-focused company

EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging


Lonza completes drug product manufacturing line in Visp
News | March 31, 2023

Lonza completes drug product manufacturing line in Visp

This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering


Govt. reviews public health preparedness for management of COVID-19
Public Health | March 28, 2023

Govt. reviews public health preparedness for management of COVID-19

States advised to undertake mock drills to ensure operational readiness of Hospital Infrastructure including Oxygen Cylinders, PSA plants, ventilators and human resources